Zhanpeng Guo
Jinzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Targeted biohybrid nanoplatform for spinal cord injury treatment: Restoring microglial mitophagy and alleviating oxidative stress.
Journal: Materials today. Bio
Published: December 17, 2025
Zinc protects against neuroinflammation after spinal cord injury by regulating mitophagy-dependent mtDNA-cGAS-STING signaling.
Journal: Free radical biology & medicine
Published: October 21, 2025
Quality assessment of DeepSeek-R1's responses to guideline-related questions on hip osteoarthritis from AAOS.
Journal: International journal of surgery (London, England)
Published: May 29, 2025
Zinc regulates microglial polarization and inflammation through IKBα after spinal cord injury and promotes neuronal repair and motor function recovery in mice.
Journal: Frontiers in pharmacology
Published: October 12, 2024
Finite element analysis of the treatment of a minimally invasive approach combined with a novel anatomical locking plate for scapular body fractures.
Journal: Journal of orthopaedic surgery and research
Published: April 07, 2024
Validation of the Chinese version of the Smartphone Distraction Scale.
Journal: Heliyon
Published: December 25, 2023
The relationship between living alone or not and depressive symptoms in older adults: a parallel mediation effect of sleep quality and anxiety.
Journal: BMC geriatrics
Published: December 06, 2022
Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3 Inflammasome Pathway.
Journal: Analytical cellular pathology (Amsterdam)
Published: November 13, 2021
Metabolomics Study of Whole-body Vibration on Lipid Metabolism of Skeletal Muscle in Aging Mice.
Journal: International journal of sports medicine
Published: October 30, 2020
miR-193-3p ameliorates bone resorption in ovariectomized mice by blocking NFATc1 signaling.
Journal: International journal of clinical and experimental pathology
Published: January 09, 2019
MiR-429 improved the hypoxia tolerance of human amniotic cells by targeting HIF-1α.
Journal: Biotechnology letters
Published: June 27, 2018
Last Updated: 09/26/2026